Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Findings from the People's Republic of China and United States in HIV/AIDS provide new insights
May 10th, 2006
Reports from the People's Republic of China and United States highlight recent research in HIV/AIDS. Study 1: Immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment induced neutralizing antibody against human immunodeficiency virus type 1 (HIV-1). "The membrane-proximal external region (MPER) of HIV-1 gp41 is recognized by all three anti-HIV antibodies 2F5, 4E10, and Z13 that were directly derived from AIDS patients and have broader anti-HIV neutralizing activities. Thus, the MPER has been the focus of anti-HIV vaccine design and development. However, it has been unsuccessful to...
Source: Vaccine Weekly (2006-05-10)
|
